25.03.2014 • NewsDOTPOxeaOxsoft GPO

Oxea Plans Capacity Increase for Plasticizer Oxsoft GPO

In order to meet strongly growing customer demand, Oxea is planning to increase its European capacity for Oxsoft GPO by 50,000 t/y by Q4/2015.

To this end, Oxea has signed a Memorandum of Understanding with an unnamed party to establish a joint production of dioctyl terephthalate (DOTP), a general-purpose plasticizer used in a wide range of applications such as construction, automotive and flooring.

"The European market for phthalate-free plasticizers is growing rapidly. As a replacement mainly for dioctyl phthalate and diisononyl phthalate, DOTP is benefiting particularly from this development and our capacities need to be planned correspondingly," said Oxea's project leader, Christian Boehmer.

Jacco de Haas, global marketing manager for Specialty Esters at the company, said: "Oxea is integrated into key raw materials for DOTP. For example, Oxea is the largest European producer of 2-Ethylhexanol, which is the main raw material for the production of DOTP. This backward integration allows us to reliably meet the high level of demand and accommodate the needs of our customers," he added.

Company

Logo:

Oxea

Rheinpromenade 4a
40789 Monheim am Rhein
Germany

Company contact







Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.